Cingulate Warrants Stock Today
| CINGW Stock | USD 0.04 0 3.31% |
PerformanceOK
| Odds Of DistressHigh
|
Cingulate Warrants is selling for under 0.0351 as of the 20th of March 2025; that is 3.31 percent down since the beginning of the trading day. The stock's lowest day price was 0.0316. Cingulate Warrants has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of December 2021 | Category Healthcare | Classification Health Care |
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of central nervous system and neurobiological disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas with an additional location in Morristown, New Jersey. More on Cingulate Warrants
Moving together with Cingulate Stock
Moving against Cingulate Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Cingulate Stock Highlights
| CEO Board | Shane PharmD | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Cingulate Warrants can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cingulate Warrants' financial leverage. It provides some insight into what part of Cingulate Warrants' total assets is financed by creditors.
| |||||
Cingulate Warrants (CINGW) is traded on NASDAQ Exchange in USA. It is located in 1901 West 47th Place, Kansas City, KS, United States, 66205 and employs 13 people. Cingulate Warrants is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
Cingulate Warrants has accumulated about 1.92 M in cash with (15.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cingulate Warrants Probability Of Bankruptcy
Cingulate Warrants Historical Income Statement
Cingulate Stock Against Markets
Cingulate Warrants Corporate Executives
Elected by the shareholders, the Cingulate Warrants' board of directors comprises two types of representatives: Cingulate Warrants inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cingulate. The board's role is to monitor Cingulate Warrants' management team and ensure that shareholders' interests are well served. Cingulate Warrants' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cingulate Warrants' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jennifer CPA | Senior CFO | Profile | |
| Dr MBA | Executive COO | Profile |
Additional Tools for Cingulate Stock Analysis
When running Cingulate Warrants' price analysis, check to measure Cingulate Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate Warrants is operating at the current time. Most of Cingulate Warrants' value examination focuses on studying past and present price action to predict the probability of Cingulate Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate Warrants' price. Additionally, you may evaluate how the addition of Cingulate Warrants to your portfolios can decrease your overall portfolio volatility.